NASHVILLE, Tenn., March 17/PRNewswire/ -- Brad Tice, Pharm.D., chief
clinical officer of PharmMD, will be named a fellow of the American
Pharmacists Association (APhA) at its upcoming annual meeting, scheduled
for March 14-17 in San Diego, Calif.

Among his many career accomplishments, Dr. Tice helped make medication
therapy management (MTM) what it is today. MTM refers to the process of
preventing drug error, overuse and abuse by ensuring that individual
patients receive the most appropriate medications possible. Dr. Tice was a
member of the team that wrote the accepted clinical definition of MTM
approved by 11 organizations including the APhA. He also participated on
the advisory panel that developed the MTM model jointly issued by APhA and
NACDS. As evidence of the increasing value and importance of MTM, the
Centers for Medicare and Medicaid Services (CMS) began in 2006 requiring
each sponsor of its Part D drug benefits to incorporate an MTM program into
their plan's benefit structure. CMS leadership has referred to MTM as the
"cornerstone" of the Part D Medicare benefit.

Dr. Tice currently serves as chief clinical officer for PharmMD, an MTM
provider that works with employers, government plans and other payers to
help ensure that beneficiaries are receiving the most appropriate
medications by improving coordination and communication among physicians,
pharmacists, payers and patients. The company analyzes medical and
pharmaceutical utilization records to prevent harmful drug interactions and
costly duplications. After only one quarter of providing MTM services to
approximately 3,000 covered lives at a large, self-insured employer,
PharmMD reported $3 saved for ever $1 spent on its services.

"As our company's clinical leader, Dr. Tice's services have likely
saved several lives and improved many more," said Bo Bartholomew, founder
and CEO of PharmMD. "He is a pioneer in his industry and a critical member
of our executive team."

The APhA Fellow Award was established in 1987 to honor members who have
demonstrated progressive, exemplary service and achievements in their
professional area through service to APhA academies and other national,
state, and local professional organizations. Recipients must have at least
10 years professional pharmacy experience.

Dr. Tice is among only 17 individuals to receive the APhA Fellow Award
this year, which is given to a maximum of 20 individuals each year. As a
member of the APhA Academy of Pharmacy Practice and Management, Dr. Tice
has held numerous leadership positions including member-at-large of the
executive committee and chair of the clinical/pharmacotherapeutic section.
He sat on the advisory board of the Journal of the American Pharmacists
Association for several years and also served as speaker of the house,
vice-speaker and member of the board of trustees of the Iowa Pharmacists
Association. He has also been actively involved in the Pharmacy Quality
Alliance (PQA) and currently serves as the co-chair of its Quality Metrics
Workgroup.

"Medication error, overuse and abuse are pressing issues in today's
healthcare environment, and, if applied properly, the principles of MTM can
go a long way to preventing these negative events," said Dr. Tice. "It is
exciting to operate on the cutting edge of such an important healthcare
trend."

Dr. Tice began his pharmacy career focusing on the delivery of patient
care services for Osco Drug, first as a pharmacist in Kansas City, Kan.,
and later as a pharmacy manager for Osco Drug in Davenport, Iowa. He later
became an assistant and associate professor at the Drake University College
of Pharmacy and Health Sciences and Director of the Osco Drug/Drake
University Community Care Laboratory. Dr. Tice earned his bachelor's of
science and doctorate in pharmacy from the University of Kansas.

Dr. Tice was awarded the Iowa Pharmacy Association Young Pharmacist of
the Year in 2001 and the 2005 Alfred B. Prescott/GlaxoSmithKline Leadership
Award.

About PharmMD

PharmMD is an MTM provider based in Brentwood, Tenn., that works with
employers and payers to help ensure that beneficiaries are receiving the
most appropriate medications. Founded in 2006, PharmMD improves
coordination and communication among physicians, pharmacists, payers and
patients by analyzing pharmacy and medical claims information and clinical
decision making. Because PharmMD focuses exclusively on MTM, the company is
able to analyze both aggregate and patient-specific data to identify trends
and conflicts to positively impact patient health and contain costs. More
information at: http://www.pharmmd.com .

About the American Pharmacists Association (APhA)

The American Pharmacists Association is dedicated to improving
medication use and advancing patient care. APhA's awards and recognition
program is American Pharmacy's most comprehensive recognition program.
Founded in 1852 as the American Pharmaceutical Association, APhA is the
first-established and largest professional association of pharmacists in
the United States. Its more than 60,000 members include pharmacists,
scientists, student pharmacists, pharmacy technicians and others interested
in advancing the profession.

(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...

(Date:10/13/2017)... ... 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... popular and least understood books in the Holy Scriptures, Revelation. The Book of Revelation ... scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins ...

(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...

(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...

(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...